Parasitic brain infections: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Differential Diagnosis == {| class="wikitable" !Parasite !Disease !Lesion !Location |- ! colspan="4" |Protozoa |- |Balamuthia mandrillaris and Acanthamoeba species..." |
m Text replacement - " species]]" to "]]" |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
==Differential Diagnosis== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Parasite |
!Parasite |
||
!Disease |
!Disease |
||
!Lesion |
!Lesion |
||
!Clinical Clues |
|||
!Location |
|||
|- |
|- |
||
! colspan="4" |Protozoa |
! colspan="4" |Protozoa |
||
|- |
|- |
||
|[[Balamuthia mandrillaris]] and [[Acanthamoeba |
|[[Balamuthia mandrillaris]] and [[Acanthamoeba]] |
||
|[[Granulomatous amoebic encephalitis]] |
|[[Granulomatous amoebic encephalitis]] |
||
|single or multiple ring-enhancing lesions with surrounding edema and mass effect |
|single or multiple ring-enhancing lesions in the gray and white matter with surrounding edema and mass effect |
||
|exposure to warm water |
|||
|gray and white matter |
|||
|- |
|- |
||
|[[Leishmania |
|[[Leishmania]] |
||
|[[Leishmaniasis]] |
|[[Leishmaniasis]] |
||
| |
| |
||
|travel to endemic country |
|||
| ⚫ | |||
|- |
|- |
||
|[[Microsporidia |
|[[Microsporidia]] |
||
|[[Microsporidiasis]] |
|[[Microsporidiasis]] |
||
| |
| |
||
| Line 25: | Line 25: | ||
|[[Naegleria fowleri]] |
|[[Naegleria fowleri]] |
||
|[[Primary amebic meningoencephalitis]] |
|[[Primary amebic meningoencephalitis]] |
||
|global edema, stroke, and elevated intracranial pressure |
|global edema, stroke, and elevated intracranial pressure, most commonly in the base of the brain |
||
|exposure to warm water, rapid progression |
|||
|base of brain most common |
|||
|- |
|- |
||
|[[Plasmodium |
|[[Plasmodium]] |
||
|Malaria |
|Malaria |
||
| |
| |
||
| Line 40: | Line 40: | ||
|[[Trypanosoma brucei]] |
|[[Trypanosoma brucei]] |
||
|[[African trypanosomiasis]] |
|[[African trypanosomiasis]] |
||
|diffuse hyperintensity on T1 |
|diffuse hyperintensity on T1 usually involving bilateral basal ganglia |
||
| ⚫ | |||
|bilateral basal ganglia |
|||
|- |
|- |
||
|[[Trypanosoma cruzi]] |
|[[Trypanosoma cruzi]] |
||
|[[Chagas disease]] |
|[[Chagas disease]] |
||
|contrast-enhancing hypointense T1 lesions with edema on T2 |
|contrast-enhancing hypointense T1 lesions involving only the parietal and frontal lobes, with edema on T2 |
||
| |
|||
|parietal and frontal lobes only |
|||
|- |
|- |
||
! colspan="4" |Metazoa: Trematodes |
! colspan="4" |Metazoa: Trematodes |
||
|- |
|- |
||
|[[Paragonimus |
|[[Paragonimus]] |
||
|Paragonimiasis |
|Paragonimiasis |
||
|inflammatory changes surrounding clusters of contrast-enhancing lesions |
|inflammatory changes surrounding clusters of contrast-enhancing lesions, most commonly in the frontal and temporal gray and white matter |
||
| |
|||
|frontal and temporal gray and white matter most common |
|||
|- |
|- |
||
|[[Schistosoma |
|[[Schistosoma]] |
||
|[[Schistosomiasis]] |
|[[Schistosomiasis]] |
||
|central linear enhancement, clustered with arborized appearance |
|central linear enhancement, clustered with arborized appearance, and commonly involves spinal cord with [[Schistosoma haematobium]] |
||
| |
|||
|can include spinal cord, especially with [[Schistosoma haematobium]] |
|||
|- |
|- |
||
! colspan="4" |Metazoa: Cestodes |
! colspan="4" |Metazoa: Cestodes |
||
| Line 64: | Line 64: | ||
|[[Echinococcus granulosus]] |
|[[Echinococcus granulosus]] |
||
|Intracranial hydatidosis |
|Intracranial hydatidosis |
||
|multiple thin-walled, large, round cysts, or one large cyst with smaller surrounding cysts |
|multiple thin-walled, large, round cysts, or one large cyst with smaller surrounding cysts, most commonly in the parietal lobe |
||
| |
|||
|parietal most common |
|||
|- |
|- |
||
|[[Echinococcus multilocularis]] |
|[[Echinococcus multilocularis]] |
||
|Alveolar hydatid disease |
|Alveolar hydatid disease |
||
|contrast-enhancing round, solid lesions with surrounding edema on T2 |
|contrast-enhancing round, solid lesions with surrounding edema on T2 |
||
| |
| |
||
|- |
|- |
||
|[[Taenia solium]] |
|[[Taenia solium]] |
||
| Line 77: | Line 77: | ||
| |
| |
||
|- |
|- |
||
|[[Taenia |
|[[Taenia]] |
||
|[[Coenurosis]] |
|[[Coenurosis]] |
||
| |
| |
||
| |
| |
||
|- |
|- |
||
|[[Spirometra |
|[[Spirometra]] |
||
|[[Sparganosis]] |
|[[Sparganosis]] |
||
|T2 edema, sometimes with T1 mass or linear or curvilinear contrast-enhancing lesions |
|T2 edema, sometimes with T1 mass or linear or curvilinear contrast-enhancing lesions, most commonly involving frontal and parietal lobes |
||
| |
|||
|frontal and parietal lobes most common |
|||
|- |
|- |
||
! colspan="4" |Metazoa: Nematodes |
! colspan="4" |Metazoa: Nematodes |
||
|- |
|- |
||
|[[Gnathostoma |
|[[Gnathostoma]] |
||
|[[Gnathostomiasis]] |
|[[Gnathostomiasis]] |
||
| |
| |
||
| Line 99: | Line 99: | ||
| |
| |
||
|- |
|- |
||
|[[Toxocara |
|[[Toxocara]] |
||
|[[Toxocariasis]] |
|[[Toxocariasis]] |
||
| |
| |
||
| Line 129: | Line 129: | ||
| |
| |
||
|- |
|- |
||
|[[Lagochilascaris |
|[[Lagochilascaris]] |
||
|[[Lagochilascariasis]] |
|[[Lagochilascariasis]] |
||
| |
| |
||
| |
| |
||
|} |
|} |
||
<br /> |
|||
== Further Reading == |
|||
* Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. ''Expert Rev Neurother''. 2016;16(4): 401–414. doi: [https://doi.org/10.1586/14737175.2016.1155454 10.1586/14737175.2016.1155454] |
|||
[[Category:Parasites]] |
[[Category:Parasites]] |
||
Latest revision as of 20:11, 12 February 2022
Differential Diagnosis
| Parasite | Disease | Lesion | Clinical Clues |
|---|---|---|---|
| Protozoa | |||
| Balamuthia mandrillaris and Acanthamoeba | Granulomatous amoebic encephalitis | single or multiple ring-enhancing lesions in the gray and white matter with surrounding edema and mass effect | exposure to warm water |
| Leishmania | Leishmaniasis | travel to endemic country | |
| Microsporidia | Microsporidiasis | ||
| Naegleria fowleri | Primary amebic meningoencephalitis | global edema, stroke, and elevated intracranial pressure, most commonly in the base of the brain | exposure to warm water, rapid progression |
| Plasmodium | Malaria | ||
| Toxoplasma gondii | Toxoplasmosis | ||
| Trypanosoma brucei | African trypanosomiasis | diffuse hyperintensity on T1 usually involving bilateral basal ganglia | |
| Trypanosoma cruzi | Chagas disease | contrast-enhancing hypointense T1 lesions involving only the parietal and frontal lobes, with edema on T2 | |
| Metazoa: Trematodes | |||
| Paragonimus | Paragonimiasis | inflammatory changes surrounding clusters of contrast-enhancing lesions, most commonly in the frontal and temporal gray and white matter | |
| Schistosoma | Schistosomiasis | central linear enhancement, clustered with arborized appearance, and commonly involves spinal cord with Schistosoma haematobium | |
| Metazoa: Cestodes | |||
| Echinococcus granulosus | Intracranial hydatidosis | multiple thin-walled, large, round cysts, or one large cyst with smaller surrounding cysts, most commonly in the parietal lobe | |
| Echinococcus multilocularis | Alveolar hydatid disease | contrast-enhancing round, solid lesions with surrounding edema on T2 | |
| Taenia solium | Neurocysticercosis | single or multiple ring-enhancing lesions, with calcifications if older | |
| Taenia | Coenurosis | ||
| Spirometra | Sparganosis | T2 edema, sometimes with T1 mass or linear or curvilinear contrast-enhancing lesions, most commonly involving frontal and parietal lobes | |
| Metazoa: Nematodes | |||
| Gnathostoma | Gnathostomiasis | ||
| Angiostrongylus cantonensis | Angiostrongyliasis | ||
| Toxocara | Toxocariasis | ||
| Strongyloides stercoralis | Strongyloidiasis | ||
| multiple | Filariasis | ||
| Baylisascaris procyonis | Baylisascariasis | ||
| Dracuncula medinensis | Dracunculiasis | ||
| Dicrocoelium dendriticum | Dicrocoeliasis | ||
| Lagochilascaris | Lagochilascariasis | ||
Further Reading
- Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. Expert Rev Neurother. 2016;16(4): 401–414. doi: 10.1586/14737175.2016.1155454